Tag: fentanyl
July 1, 2017
HotSpot Phase II Initial Report Released
The Northeast Node, alongside partners at our parent institution from the Dartmouth Center for Technology and Behavioral Health (CTBH), have released the initial findings from our Phase II HotSpot study, Understanding Opioid Overdoses in New Hampshire.
February 7, 2017
Dr. Lisa Marsch testifies at House Bipartisan Heroin Task Force on NH fentanyl overdose crisis
On Monday, February 6, Dr. Lisa Marsch, Director of the Northeast Node and the Center for Technology and Behavioral Health (CTBH), testified at a Congressional briefing of the House Bipartisan Heroin Task Force.
January 8, 2017
Node study featured in Union Leader
The Northeast Node’s Phase 2 Fentanyl Hot Spot study, Understanding Opioid Overdoses in New Hampshire, was recently featured in the Union Leader. The article explains New Hampshire’s fentanyl-related overdose crisis and how the study aims to answer the question: Why does New Hampshire have such a big problem? You can read the full article here.
September 6, 2016
Node awarded Phase 2 of New Hampshire Fentanyl HotSpot Study
In partnership with the National Drug Early Warning System (NDEWS), the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) has been awarded funds to complete the second phase of the Fentanyl Hot Spot Study conducted in New Hampshire earlier this summer.